Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Sep 2022. Module: Canada Health Infoway English module (core metadata concept)
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 180701000087110 | Supemtek 45 micrograms per 0.5 milliliter solution for injection Sanofi Pasteur Limited (real clinical drug) | en | Fully specified name | Active | Entire term case sensitive (core metadata concept) | Canada Health Infoway English module (core metadata concept) |
| 180711000087112 | Supemtek 45 micrograms per 0.5 milliliter solution for injection Sanofi Pasteur Limited | en | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | Canada Health Infoway English module (core metadata concept) |
| 180721000087116 | Inf Supemtek SP | en | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | Canada Health Infoway English module (core metadata concept) |
| 180751000087111 | Inf Supemtek SP | fr | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | Canada Health Infoway French module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Supemtek 45 micrograms per 0.5 milliliter solution for injection Sanofi Pasteur Limited (real clinical drug) | est un(e) (attribut) | Vaccine product containing only influenza A virus subtypes H1N1 and H3N2 and influenza B virus Victoria and Yamagata lineage antigens (medicinal product) | true | Inferred relationship | Some | ||
| Supemtek 45 micrograms per 0.5 milliliter solution for injection Sanofi Pasteur Limited (real clinical drug) | a pour principe actif (attribut) | Influenza A virus subtype H3N2 antigen | true | Inferred relationship | Some | 1 | |
| Supemtek 45 micrograms per 0.5 milliliter solution for injection Sanofi Pasteur Limited (real clinical drug) | est un(e) (attribut) | Vaccine product containing only Influenza virus antigen in parenteral dose form | true | Inferred relationship | Some | ||
| Supemtek 45 micrograms per 0.5 milliliter solution for injection Sanofi Pasteur Limited (real clinical drug) | Has product characteristic | Unadjuvanted vaccine product (qualifier value) | true | Inferred relationship | Some | ||
| Supemtek 45 micrograms per 0.5 milliliter solution for injection Sanofi Pasteur Limited (real clinical drug) | a une forme pharmaceutique (attribut) | forme pharmaceutique pour usage parentéral (forme pharmaceutique) | true | Inferred relationship | Some | ||
| Supemtek 45 micrograms per 0.5 milliliter solution for injection Sanofi Pasteur Limited (real clinical drug) | a pour principe actif (attribut) | Influenza B virus Yamagata lineage antigen | true | Inferred relationship | Some | 2 | |
| Supemtek 45 micrograms per 0.5 milliliter solution for injection Sanofi Pasteur Limited (real clinical drug) | Plays role | Active immunity stimulant role (role) | true | Inferred relationship | Some | ||
| Supemtek 45 micrograms per 0.5 milliliter solution for injection Sanofi Pasteur Limited (real clinical drug) | Has supplier | Sanofi Pasteur SA (supplier) | true | Inferred relationship | Some | ||
| Supemtek 45 micrograms per 0.5 milliliter solution for injection Sanofi Pasteur Limited (real clinical drug) | a pour principe actif (attribut) | Influenza B virus Victoria lineage antigen | true | Inferred relationship | Some | 3 | |
| Supemtek 45 micrograms per 0.5 milliliter solution for injection Sanofi Pasteur Limited (real clinical drug) | a pour principe actif (attribut) | Influenza A virus subtype H1N1 antigen | true | Inferred relationship | Some | 4 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Canada English language reference set (foundation metadata concept)
Administered tradename codes for vaccines reference set (foundation metadata concept)
Description inactivation indicator reference set
FHIR